Erythropoietin and ischemic conditioning -: why two good things may be bad

被引：9
作者：
Buehrer, Christoph
Felderhoff-Mueser, Ursula
Wellmann, Sven
机构：
[1] Univ Basel, Childrens Hosp, Dept Neonatol, Basel, Switzerland
[2] Charite, Ctr Med, Dept Neonatol, Berlin, Germany
来源：
ACTA PAEDIATRICA | 2007年 / 96卷 / 06期
关键词：
brain; erythropoietin; ischemia;
D O I：
10.1111/j.1651-2227.2007.00335.x
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：787 / 789
页数：3
相关论文
共 29 条
[1]   Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa [J].
Banks, WA ;
Jumbe, NL ;
Farrell, CL ;
Niehoff, ML ;
Heatherington, AC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 505 (1-3) :93-101
[2]   Quantification of cerebrospinal fluid proteins in children by high-resolution agarose gel electrophoresis [J].
Barnard, K ;
Herold, R ;
Siemes, H ;
Siegert, M .
JOURNAL OF CHILD NEUROLOGY, 1998, 13 (02) :51-58
[3]   Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells [J].
Beleslin-Cokic, BB ;
Cokic, VP ;
Yu, XB ;
Weksler, BB ;
Schechter, AN ;
Noguchi, CT .
BLOOD, 2004, 104 (07) :2073-2080
[4]   Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain [J].
Bernaudin, M ;
Nedelec, AS ;
Divoux, D ;
MacKenzie, ET ;
Petit, E ;
Schumann-Bard, P .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2002, 22 (04) :393-403
[5]   Emerging biological roles for erythropoietin in the nervous system [J].
Brines, M ;
Cerami, A .
NATURE REVIEWS NEUROSCIENCE, 2005, 6 (06) :484-494
[6]   Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor [J].
Brines, M ;
Grasso, G ;
Fiordaliso, F ;
Sfacteria, A ;
Ghezzi, P ;
Fratelli, M ;
Latini, R ;
Xie, QW ;
Smart, J ;
Su-Rick, CJ ;
Pobre, E ;
Diaz, D ;
Gomez, D ;
Hand, C ;
Coleman, T ;
Cerami, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (41) :14907-14912
[7]   Hematocrit was not validated as a surrogate end point for survival among epoetin-treated hemodialysis patients [J].
Cotter, DJ ;
Stefanik, K ;
Zhang, Y ;
Thamer, M ;
Scharfstein, D ;
Kaufman, J .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2004, 57 (10) :1086-1095
[8]   Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity [J].
Dzietko, M ;
Felderhoff-Mueser, U ;
Sifringer, M ;
Krutz, B ;
Bittigau, P ;
Thor, F ;
Heumann, R ;
Bührer, C ;
Ikonomidou, C ;
Hansen, HH .
NEUROBIOLOGY OF DISEASE, 2004, 15 (02) :177-187
[9]   A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain [J].
Ehrenreich, H ;
Hasselblatt, M ;
Knerlich, F ;
von Ahsen, N ;
Jacob, S ;
Sperling, S ;
Woldt, H ;
Vehmeyer, K ;
Nave, KA ;
Sirén, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (03) :862-867
[10]   Erythropoietin therapy for acute stroke is both safe and beneficial [J].
Ehrenreich, H ;
Hasselblatt, M ;
Dembowski, C ;
Cepek, L ;
Lewczuk, P ;
Stiefel, M ;
Rustenbeck, HH ;
Breiter, N ;
Jacob, S ;
Knerlich, F ;
Bohn, M ;
Poser, W ;
Rüther, E ;
Kochen, M ;
Gefeller, O ;
Gleiter, C ;
Wessel, TC ;
De Ryck, M ;
Itri, L ;
Prange, H ;
Cerami, A ;
Brines, M ;
Sirén, AL .
MOLECULAR MEDICINE, 2002, 8 (08) :495-505
123